NasdaqGS - Delayed Quote USD

Varex Imaging Corporation (VREX)

8.42
+0.05
+(0.60%)
At close: June 6 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
827,500
811,000
893,400
859,400
818,100
Cost of Revenue
548,300
554,100
603,100
575,900
546,600
Gross Profit
279,200
256,900
290,300
283,500
271,500
Operating Expense
225,700
224,800
213,200
195,300
197,400
Operating Income
53,500
32,100
77,100
88,200
74,100
Net Non Operating Interest Income Expense
-24,600
-22,900
-25,600
-39,400
-42,000
Other Income Expense
-12,300
-4,200
-20,200
-4,300
-3,500
Pretax Income
16,600
5,000
31,300
44,500
28,600
Tax Provision
58,000
52,200
-17,400
13,700
10,700
Net Income Common Stockholders
-42,000
-47,700
48,200
30,300
17,400
Average Dilution Earnings
0
0
6,200
0
--
Diluted NI Available to Com Stockholders
-42,000
-47,700
54,400
30,300
17,400
Basic EPS
-1.03
-1.17
1.20
0.76
0.44
Diluted EPS
-1.03
-1.17
1.08
0.73
0.43
Basic Average Shares
41,100
40,800
40,300
39,800
39,300
Diluted Average Shares
41,100
40,800
50,300
41,600
40,300
Total Operating Income as Reported
53,500
32,100
77,100
88,200
74,100
Total Expenses
774,000
778,900
816,300
771,200
744,000
Net Income from Continuing & Discontinued Operation
-42,000
-47,700
48,200
30,300
17,400
Normalized Income
-41,842
-47,542
61,946
31,338
17,525.20
Interest Income
8,600
7,300
3,700
400
100
Interest Expense
30,000
26,800
26,700
36,400
38,600
Net Interest Income
-24,600
-22,900
-25,600
-39,400
-42,000
EBIT
46,600
31,800
58,000
80,900
67,200
EBITDA
73,900
62,900
91,200
114,500
104,500
Reconciled Cost of Revenue
548,300
554,100
603,100
575,900
546,600
Reconciled Depreciation
27,300
31,100
33,200
33,600
37,300
Net Income from Continuing Operation Net Minority Interest
-42,000
-47,700
48,200
30,300
17,400
Total Unusual Items Excluding Goodwill
-200
-200
-17,400
-1,500
-200
Total Unusual Items
-200
-200
-17,400
-1,500
-200
Normalized EBITDA
74,100
63,100
108,600
116,000
104,700
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-42
-42
-3,654
-462
-74.80
9/30/2021 - 1/23/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IMP-A-SDB.ST Implantica AG
41.40
-3.50%
 
LIVN LivaNova PLC
45.95
+2.45%
 
IRIX IRIDEX Corporation
0.9732
+1.38%
 
ITGR Integer Holdings Corporation
121.33
+0.36%
 
AVNS Avanos Medical, Inc.
12.46
+1.05%
 
214680.KQ DRTECH Corporation
1,980.00
+3.34%
 
688607.SS CareRay Digital Medical Technology Co., Ltd.
19.18
-0.31%
 
BSX.BE Boston Scientific Corp
89.00
-0.89%
 
NEOLA.ST Neola Medical AB (publ)
2.2500
-3.02%
 
PHBA.F Sonova Holding AG
53.50
+0.94%